MedPath

A Maastricht Contrast-Induiced-Nehropathy Guideline study (AMACING): prevention guidelines - appropriate and cost effective?

Completed
Conditions
acute kidney injury (AKI)
acute renal insufficiency
10029149
Registration Number
NL-OMON44751
Lead Sponsor
Medisch Universitair Ziekenhuis Maastricht
Brief Summary

Trial is onging in other countries

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
660
Inclusion Criteria

patients *18 years of age, with moderate renal insufficiency (eGFR *30ml/min/1.73m2), referred for prophylactic intravenous hydration before and after an elective contrast procedure.

Exclusion Criteria

emergency or intensive care patients, patients receiving or having received renal replacement therapy, patients with severe renal insufficiency (eGFR <30ml/min/1.73m2), patients <18 years of age, patients unable or unwilling to personally give informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The aim of the guidelines is to prevent CIN. Therefore, even though clinically<br /><br>relevant outcomes would be a preferable outcome measure, an evaluation of the<br /><br>(cost) effectiveness of the prophylactic treatment prescribed by these<br /><br>guidelines must have CIN incidence as primary outcome measure.<br /><br>The costs per CIN case prevented will be calculated based on the absolute<br /><br>difference in CIN incidence between the randomized groups with and without<br /><br>prophylactic intravenous hydration (non-inferiority randomized trial).<br /><br><br /><br>In addition, we will evaluate the performance of prophylactic intravenous<br /><br>hydration in the prevention of the clinically relevant effects: decrease in<br /><br>renal function, renal damage and 30-day morbidity/mortality. In the evaluation,<br /><br>we shall take complications of prophylactic intravenous hydration into account.</p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath